Literature DB >> 19949081

Cutting edge: limited specialization of dendritic cell subsets for MHC class II-associated presentation of viral particles.

Susanne A Keller1, Monika Bauer, Vania Manolova, Simone Muntwiler, Philippe Saudan, Martin F Bachmann.   

Abstract

Dendritic cells (DCs) are the most important APC. It was recently reported that there is a dichotomy for Ag presentation by DC subsets; exogenous Ags reach the MHC class I pathway, but not the MHC class II pathway, in CD8(+) DCs, whereas CD8(-) DCs only process Ags for the MHC class II pathway. In this study, we used virus-like particles (VLPs) to show that CD8(+) and CD8(-) DCs efficiently capture and process VLPs for presentation in association with MHC class II in vivo. In contrast, CD8(+) DCs, but not CD8(-) DCs, cross presented VLP-derived peptides. This pattern was changed in an FcgammaR-dependent fashion in the presence of VLP-specific Abs, because under those conditions both DC subsets failed to efficiently cross present. Thus, the presentation of viral particles to CD4(+) T cells is not restricted to distinct DC subsets, whereas the presentation of viral particles to CD8(+) T cells is limited to CD8(+) DCs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19949081     DOI: 10.4049/jimmunol.0901540

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.

Authors:  Martin F Bachmann; Gary T Jennings
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

Review 2.  Virus-like particles as antigenic nanomaterials for inducing protective immune responses in the lung.

Authors:  Agnieszka Rynda-Apple; Dustin P Patterson; Trevor Douglas
Journal:  Nanomedicine (Lond)       Date:  2014       Impact factor: 5.307

3.  Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

Authors:  Sarah L Jongbloed; Andrew J Kassianos; Kylie J McDonald; Georgina J Clark; Xinsheng Ju; Catherine E Angel; Chun-Jen J Chen; P Rod Dunbar; Robert B Wadley; Varinder Jeet; Annelie J E Vulink; Derek N J Hart; Kristen J Radford
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

4.  Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles.

Authors:  Suvi Lappalainen; Kirsi Tamminen; Timo Vesikari; Vesna Blazevic
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

Review 5.  Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

Authors:  Sharan Bobbala; Sarah Hook
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.580

6.  An overview on the field of micro- and nanotechnologies for synthetic Peptide-based vaccines.

Authors:  Aiala Salvador; Manoli Igartua; Rosa Maria Hernández; José Luis Pedraz
Journal:  J Drug Deliv       Date:  2011-06-15

7.  Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccines.

Authors:  Darren B Leneghan; Kazutoyo Miura; Iona J Taylor; Yuanyuan Li; Jing Jin; Karl D Brune; Martin F Bachmann; Mark Howarth; Carole A Long; Sumi Biswas
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379

8.  Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector.

Authors:  Anita F Meier; Mark Suter; Elisabeth M Schraner; Bruno M Humbel; Kurt Tobler; Mathias Ackermann; Andrea S Laimbacher
Journal:  Int J Mol Sci       Date:  2017-02-16       Impact factor: 5.923

Review 9.  SARS-CoV-2 reinfection and implications for vaccine development.

Authors:  Firzan Nainu; Rufika Shari Abidin; Muh Akbar Bahar; Andri Frediansyah; Talha Bin Emran; Ali A Rabaan; Kuldeep Dhama; Harapan Harapan
Journal:  Hum Vaccin Immunother       Date:  2020-12-01       Impact factor: 3.452

10.  Head-to-Head Comparison of Modular Vaccines Developed Using Different Capsid Virus-Like Particle Backbones and Antigen Conjugation Systems.

Authors:  Laurits Fredsgaard; Louise Goksøyr; Susan Thrane; Kara-Lee Aves; Thor G Theander; Adam F Sander
Journal:  Vaccines (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.